Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Overview of drug induced liver injury in Brazil: What is the role of public health policy on the evidence? | World J Gastrointest Pharmacol Ther | 2021 | 34046243 | PubTator, text mining | PubMed |
| A first-in-human oral dose study of mesdopetam (IRL790) to assess its safety, tolerability, and pharmacokinetics in healthy male volunteers. | Pharmacol Res Perspect | 2021 | 34018344 | PubTator, text mining | PubMed |
| MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration. | Nature | 2021 | 34012113 | PubTator, text mining | PubMed |
| NAT2 knockdown inhibits the development of colorectal cancer and its clinical significance. | Eur Rev Med Pharmacol Sci | 2021 | 34002819 | PubTator, text mining | PubMed |
| Model Based Evaluation of Hypersensitivity Adverse Drug Reactions to Antimicrobial Agents in Children. | Front Pharmacol | 2021 | 33995043 | PubTator, text mining | PubMed |
| Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data. | Drug Metab Rev | 2021 | 33989099 | PubTator, text mining | PubMed |
| Revisiting hemochromatosis: genetic vs. phenotypic manifestations. | Ann Transl Med | 2021 | 33987429 | PubTator, text mining | PubMed |
| Design and conduct considerations for studies in patients with impaired renal function. | Clin Transl Sci | 2021 | 33982447 | PubTator, text mining | PubMed |
| 3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration. | Clin Transl Sci | 2021 | 33982436 | PubTator, text mining | PubMed |
| CYP2E1, GSTM1, and GSTT1 genetic polymorphisms and their associations with susceptibility to antituberculosis drug-induced liver injury in Thai tuberculosis patients. | Heliyon | 2021 | 33981901 | PubTator, text mining | PubMed |
| Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. | Front Pharmacol | 2021 | 33981213 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Pharmacogenetics to guide cardiovascular drug therapy. | Nat Rev Cardiol | 2021 | 33953382 | PubTator, text mining | PubMed |
| Cytotoxicity and genotoxicity of the carcinogen aristolochic acid I (AA-I) in human bladder RT4 cells. | Arch Toxicol | 2021 | 33938965 | PubTator, text mining | PubMed |
| NAT2 polymorphisms associated with the development of hepatotoxicity after first-line tuberculosis treatment in Mexican patients: From genotype to molecular structure characterization. | Clin Chim Acta | 2021 | 33932406 | PubTator, text mining | PubMed |
| A Yeast-Based Screening Unravels Potential Therapeutic Molecules for Mitochondrial Diseases Associated with Dominant ANT1 Mutations. | Int J Mol Sci | 2021 | 33923309 | PubTator, text mining | PubMed |
| The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development. | Int J Mol Sci | 2021 | 33923108 | PubTator, text mining | PubMed |
| A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient. | Cancers (Basel) | 2021 | 33922695 | PubTator, text mining | PubMed |
| Applicability of Artificial Vascularized Liver Tissue to Proteomic Analysis. | Micromachines (Basel) | 2021 | 33920367 | PubTator, text mining | PubMed |
| A simple method to measure sulfonation in man using paracetamol as probe drug. | Sci Rep | 2021 | 33907224 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=34